Krempl Christine D, Wnekowicz Anna, Lamirande Elaine W, Nayebagha Giw, Collins Peter L, Buchholz Ursula J
Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Freiburg, Germany.
J Virol. 2007 Sep;81(17):9490-501. doi: 10.1128/JVI.00364-07. Epub 2007 Jun 13.
Pneumonia virus of mice (PVM) is a murine relative of human respiratory syncytial virus (HRSV). Here we developed a reverse genetics system for PVM based on a consensus sequence for virulent strain 15. Recombinant PVM and a version engineered to express green fluorescent protein replicated as efficiently as the biological parent in vitro but were 4- and 12.5-fold attenuated in vivo, respectively. The G proteins of HRSV and PVM have been suggested to contribute to viral pathogenesis, but this had not been possible to study in a defined manner in a fully permissive host. As a first step, we evaluated recombinant mutants bearing a deletion of the entire G gene (Delta G) or expressing a G protein lacking its cytoplasmic tail (Gt). Both G mutants replicated as efficiently in vitro as their recombinant parent, but both were nonpathogenic in mice at doses that would otherwise be lethal. We could not detect replication of the Delta G mutant in mice, indicating that its attenuation is based on a severe reduction in the virus load. In contrast, the Gt mutant appeared to replicate as efficiently in mice as its recombinant parent. Thus, the reduction in virulence associated with the Gt mutant could not be accounted for by a reduction in viral replication. These results identified the cytoplasmic tail of G as a virulence factor whose effect is not mediated solely by the viral load. In addition to its intrinsic interest, a recombinant virus that replicates with wild-type-like efficiency but does not cause disease defines optimal properties for vaccine development.
小鼠肺炎病毒(PVM)是人类呼吸道合胞病毒(HRSV)的鼠类同源病毒。在此,我们基于强毒株15的共有序列开发了一种PVM反向遗传学系统。重组PVM以及经基因工程改造以表达绿色荧光蛋白的PVM版本在体外的复制效率与亲代病毒相同,但在体内的毒力分别减弱了4倍和12.5倍。有人认为HRSV和PVM的G蛋白有助于病毒致病,但此前无法在完全允许病毒复制的宿主中以明确的方式对此进行研究。作为第一步,我们评估了携带整个G基因缺失(ΔG)或表达缺乏胞质尾的G蛋白(Gt)的重组突变体。两种G突变体在体外的复制效率与其重组亲代相同,但在通常会致死的剂量下对小鼠均无致病性。我们在小鼠中未检测到ΔG突变体的复制,这表明其毒力减弱是基于病毒载量的大幅降低。相比之下,Gt突变体在小鼠中的复制效率似乎与其重组亲代相同。因此,与Gt突变体相关的毒力降低不能用病毒复制减少来解释。这些结果确定了G蛋白的胞质尾是一种毒力因子,其作用并非仅由病毒载量介导。除了其内在的研究价值外,一种以野生型样效率复制但不引起疾病的重组病毒为疫苗开发定义了最佳特性。